4.4 Article

Biosafety legislation and the regulatory status of the products of precision breeding in the Latin America and the Caribbean region

Journal

PLANTS PEOPLE PLANET
Volume 4, Issue 3, Pages 214-231

Publisher

WILEY
DOI: 10.1002/ppp3.10243

Keywords

biosafety law; biotechnology; Cartagena Protocol on Biosafety; Latin America and the Caribbean; living modified organism; precision breeding

Funding

  1. Swedish Foundation for Strategic Environmental Research (MISTRA)
  2. Plant Genetic Resources International Platform

Ask authors/readers for more resources

This article examines the regulatory status of precision breeding products in Latin America and the Caribbean, providing recommendations based on domestic biosafety legal frameworks and survey results. It categorizes countries into five groups based on their approach to defining LMOs, highlighting the importance of adopting the legal definition according to the Cartagena Protocol. Ambiguity in terms and the need for administrative procedures to determine regulatory status are also discussed, with the recognition of the connection between adoption of procedures and national economic and political perspectives.
It is still uncertain whether the products of precision breeding will be considered and regulated as living modified organisms (LMOs) or not. This article illustrates current regulatory matters of precision breeding in the Latin America and the Caribbean (LAC) region and provides recommendations to support the corresponding legal interpretation. This is done by analyzing domestic biosafety legal frameworks of LMOs, together with the results from a survey sent to regulatory officers and public researchers in the region. Previous similar publications have focused on a limited selection of countries in the region, but this is the first time a comprehensive overview of all 33 countries is presented. Our results classify countries in five main groups based on their approach to define LMOs under domestic biosafety legislation. Most notably, the key criterion for the clustering of countries is whether the legislation has adopted the legal definition of LMOs according to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity or not. This article highlights that the lack of clarification on the meaning of major terms, such as naturally, manipulation, and a novel combination of genetic material, can provoke ambiguity when applying the biosafety law in products derived from precision breeding. Also, countries require to adopt administrative procedures to determine the regulatory status of precision breeding products. Finally, this article suggests that the rapid adoption of such procedures relevant to precision breeding is strongly connected to the role of agriculture and biotechnology in the countries and with national economic and political perspectives.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available